JOINT FILING AGREEMENTJoint Filing Agreement • May 8th, 2014 • Levin Capital Strategies, L.P. • Laboratory analytical instruments
In accordance with Rule 13d-1(f) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Entities (as such term is defined in the Schedule 13G) on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Class A Common Stock, Par Value $0.0001 per share, of Bio-Rad Laboratories, Inc., and that this Agreement is included as an Exhibit to such joint filing. This Agreement may be executed in any number of counterparts all of which taken together shall constitute one and the same instrument.
